Glomerular Filtration Rate (eGFR) Kidney Function Calculator
Calculate Estimated Glomerular Filtration Rate (eGFR) and Chronic Kidney Disease (CKD) stages using the 2021 race-free CKD-EPI equation.
All formulas and computation matrices for this calculator execute directly in your browser with zero latency. Enter your parameters to see instant results.
Who Uses This Calculation & Why Accuracy Matters
Nephrologists, primary care physicians, clinical pharmacists, and laboratory specialists use this calculator to estimate Glomerular Filtration Rate (eGFR) to detect chronic kidney disease (CKD), stage renal impairment, and adjust pharmaceutical drug dosing using the official 2021 race-free CKD-EPI creatinine equation.
A 64-year-old female with hypertension, serum creatinine 1.35 mg/dL, screening for asymptomatic renal decline.
An oncologist evaluating a 52-year-old male cancer patient with serum creatinine 0.95 mg/dL prior to administering nephrotoxic cisplatin.
A radiologist verifying kidney function prior to contrast-enhanced computed tomography (threshold eGFR ≥ 30 mL/min).
KDIGO 2024 Clinical Chronic Kidney Disease (CKD) Staging & Prognosis
Official clinical stages of chronic kidney disease based on Glomerular Filtration Rate (KDIGO Clinical Practice Guideline).
| CKD Stage | eGFR Range (mL/min/1.73m²) | Kidney Function Status | Clinical Manifestations / Complications | Recommended Medical Actions |
|---|---|---|---|---|
| Stage G1 | ≥ 90 | Normal or High (with kidney damage/proteinuria) | Usually asymptomatic; microalbuminuria | Annual screening, blood pressure control (< 120/80) |
| Stage G2 | 60 – 89 | Mildly Decreased (with kidney damage) | Subtle decline in filtration; asymptomatic | Risk reduction, cardiovascular risk management |
| Stage G3a | 45 – 59 | Mild-to-Moderately Decreased | Early anemia, mild bone mineral disorder | Nephrology consultation, medication dose adjustments |
| Stage G3b | 30 – 44 | Moderately-to-Severely Decreased | Fluid retention, metabolic acidosis, hyperkalemia | Active nephrology management, dietary phosphorus limit |
| Stage G4 | 15 – 29 | Severely Decreased (Severe CKD) | Anemia, fatigue, electrolyte disturbances | Vascular access planning (AV fistula), transplant eval |
| Stage G5 (ESKD) | < 15 | Kidney Failure (End-Stage Renal Disease) | Uremia, fluid overload, severe hyperkalemia | Renal replacement therapy (Hemodialysis / Peritoneal / Transplant) |
* KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (Kidney International).
Official 2021 CKD-EPI Race-Free Creatinine Equation
Endorsed by the National Kidney Foundation (NKF) and American Society of Nephrology (ASN). Eliminates race as a clinical variable.
Blood serum creatinine level measured in mg/dL (or μmol/L / 88.4).
Age in completed years.
Mathematical scaling constant standardized to 1.73 m² body surface area.
Step-by-Step Worked Examples with Real Numbers
Worked Example 1: 60-Year-Old Female with Scr = 1.2 mg/dL
Creatinine term.
Exponential scaling.
Age scaling.
eGFR result.
Worked Example 2: 45-Year-Old Male with Scr = 0.8 mg/dL
Low creatinine exponent.
Age component.
Normal renal function.
Assumptions, Edge Cases & Common Calculation Mistakes
ℹ Underlying Algorithm Assumptions
- Assumes steady-state serum creatinine (not valid for acute kidney injury / AKI with rapidly shifting levels).
- Assumes adult aged 18 and older (pediatric patients require the Schwartz bedside equation).
- Normalized to standard adult body surface area of 1.73 m².
⚠ 3 Common Mistakes to Avoid
- High muscularity distortion: Bodybuilders and strength athletes with elevated muscle mass produce more creatinine, yielding a falsely low eGFR (Cystatin C testing resolves this).
- Using serum creatinine immediately following high cooked red meat intake or intense resistance exercise.
- Applying the outdated 2009 CKD-EPI equation containing race adjustment factors, which has been formally retired by the NKF and ASN.
Frequently Asked Questions
Why was race removed from the 2021 CKD-EPI eGFR equation?
The joint NKF-ASN Task Force retired the race modifier because race is a social construct rather than a biological determinant. The race-free 2021 equation eliminates diagnostic disparities that delayed Black patients from receiving timely nephrology referrals and kidney transplants.
What is Cystatin C and when should it be tested?
Cystatin C is a low-molecular-weight protein produced by all nucleated cells at a constant rate, unaffected by muscle mass, diet, or sex. When creatinine eGFR is borderline (45–59 mL/min) or muscle mass is abnormal, checking Cystatin C confirms true kidney function.
Why does eGFR naturally decline with age?
Healthy humans naturally lose nephrons (functional kidney filtering units) after age 30–40, causing eGFR to decline by approximately 0.8 to 1.0 mL/min/1.73m² per year as part of normal biological aging without overt renal disease.
What is the difference between eGFR and Creatinine Clearance (CrCl)?
eGFR is normalized to a standard body surface area (1.73 m²) for diagnosing chronic kidney disease. Creatinine Clearance (Cockcroft-Gault equation) uses total body weight and is specifically used by pharmacists for drug dosage adjustments.
Can damaged kidneys improve their eGFR?
While chronic nephron scarring is irreversible, treating underlying reversible causes (such as lowering severe blood pressure, managing blood sugar, stopping NSAID medications, and treating dehydration) can significantly improve functional eGFR and halt disease progression.